+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Early Phase 1
Age: 21Years - 65Years
All Genders
ID07737054

Pilot Trial of Psilocybin-Assisted Trauma-Focused Psychotherapy for Adults with Post-Traumatic Stress Disorder

Led by Tel-Aviv Sourasky Medical Center · Updated on 2026-07-30

13

Participants Needed

1

Research Sites

4 weeks

Total Duration

AI-Summary

What This Trial Is About

This research aims to assess the safety, tolerability, and preliminary clinical effects of psilocybin-enhanced trauma-focused psychotherapy in adults with post-traumatic stress disorder PTSD. PTSD is a chronic condition with symptoms like intrusive memories, avoidance, mood changes, and hyperarousal. Despite existing treatments, many patients do not find sufficient relief, so this pilot study explores a new approach combining psilocybin, a psychedelic compound, with trauma-focused therapy based on Acceptance and Commitment Therapy and Narrative Exposure Therapy. Participants undergo a structured treatment including preparatory psychotherapy sessions, followed by two oral psilocybin dosing sessions 15 mg first, then 25 mg administered in a controlled clinical setting with medical supervision. Each dosing session lasts about six hours, after which integration psychotherapy sessions help process trauma and incorporate insights. The study physician monitors safety throughout and can stop dosing if needed. The study includes a total of 13 participants to gather preliminary data for future research. During the study, participants receive clinical evaluations, symptom assessments using the Clinician-Administered PTSD Scale for DSM-5 CAPS-5, and safety monitoring from dosing through 30 days after completing therapy. Adverse events and tolerability are tracked as primary outcomes, while changes in PTSD symptom severity serve as secondary measures. Participants attend multiple therapy sessions and remain in clinical care during dosing, with follow-up visits to evaluate lasting effects and ensure safety.

CONDITIONS

Brief Title

Trauma-informed Psilocybin Assisted Psychotherapy (TiPAP) for PTSD

Research Team

A

Ayelet Or-Borichev, PhD

J

Jackob Nimrod Keynan, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here